Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug:158:104933.
doi: 10.1016/j.phrs.2020.104933. Epub 2020 May 20.

Letter to the Editor in response to the article "Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?"

Gabriele Ceccarelli  1 , Katiuscia Nardi  2 , Francesca Marchesani  3
Affiliations
Comment

Letter to the Editor in response to the article "Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?"

Gabriele Ceccarelli et al. Pharmacol Res. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors, Gabriele Ceccarelli, Katiuscia Nardi and Francesca Marchesani, declares no conflict of interest.

Comment on

References

    1. Casillo G.M., Mansour A.A., Raucci F., Saviano A., Mascolo N., Jilani Iqbal A., Maione F. Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome? Pharmacol. Res. 2020;(April) doi: 10.1016/j.phrs.2020.104791. - DOI - PMC - PubMed
    1. Henderson L.A., Canna S.W., Schulert G.S., Volpi S., Lee P.Y., Kernan K.F., Caricchio R., Mahmud S., Hazen M.M., Halyabar O., Hoyt K.J., Han J., Grom A.A., Gattorno M., Ravelli A., de Benedetti F., Behrens E.M., Cron R.Q., Nigrovic P.A. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 2020;(April) doi: 10.1002/art.41285. - DOI - PMC - PubMed
    1. Luo P., Liu Y., Qiu L., Liu X., Liu D., Li J. Tocilizumab treatment in COVID-19: a single center experience. J. Med. Virol. 2020;(April) doi: 10.1002/jmv.25801. - DOI - PMC - PubMed
    1. Pascarella G., Strumia A., Piliego C., Bruno F., Del Buono R., Costa F., Scarlata S., Agrò F.E. COVID-19 diagnosis and management: a comprehensive review. J. Intern. Med. 2020;(April) doi: 10.1111/joim.13091. - DOI - PMC - PubMed
    1. Hu Y., Sun J., Dai Z., Deng H., Li X., Huang Q., Wu Y., Sun L. Y. Xu., Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J. Clin. Virol. 2020;127(April) doi: 10.1016/j.jcv.2020.104371. - DOI - PMC - PubMed